Encompass Health Co. (NYSE:EHC) Shares Sold by Teacher Retirement System of Texas

Teacher Retirement System of Texas cut its stake in Encompass Health Co. (NYSE:EHC) by 13.6% during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 46,185 shares of the company’s stock after selling 7,243 shares during the period. Teacher Retirement System of Texas’ holdings in Encompass Health were worth $4,265,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors also recently modified their holdings of EHC. Miracle Mile Advisors LLC lifted its position in Encompass Health by 3.0% in the 4th quarter. Miracle Mile Advisors LLC now owns 3,835 shares of the company’s stock valued at $354,000 after purchasing an additional 112 shares during the last quarter. US Bancorp DE raised its holdings in shares of Encompass Health by 9.6% during the fourth quarter. US Bancorp DE now owns 1,380 shares of the company’s stock valued at $127,000 after buying an additional 121 shares during the last quarter. Signaturefd LLC boosted its position in shares of Encompass Health by 21.6% during the fourth quarter. Signaturefd LLC now owns 704 shares of the company’s stock worth $65,000 after buying an additional 125 shares during the period. CBIZ Investment Advisory Services LLC grew its holdings in Encompass Health by 38.7% in the 4th quarter. CBIZ Investment Advisory Services LLC now owns 455 shares of the company’s stock worth $42,000 after buying an additional 127 shares in the last quarter. Finally, MassMutual Private Wealth & Trust FSB increased its position in Encompass Health by 87.8% in the 4th quarter. MassMutual Private Wealth & Trust FSB now owns 293 shares of the company’s stock valued at $27,000 after acquiring an additional 137 shares during the period. Institutional investors and hedge funds own 97.25% of the company’s stock.

Analysts Set New Price Targets

EHC has been the subject of several recent analyst reports. William Blair reissued an “outperform” rating on shares of Encompass Health in a research note on Friday, February 7th. Royal Bank of Canada reissued an “outperform” rating and set a $110.00 target price on shares of Encompass Health in a research note on Tuesday, February 11th. StockNews.com raised shares of Encompass Health from a “hold” rating to a “buy” rating in a research note on Saturday, February 15th. Barclays raised their price objective on shares of Encompass Health from $116.00 to $118.00 and gave the company an “overweight” rating in a research note on Friday, February 7th. Finally, KeyCorp upped their target price on Encompass Health from $117.00 to $120.00 and gave the stock an “overweight” rating in a research report on Monday, February 10th. Ten equities research analysts have rated the stock with a buy rating and two have assigned a strong buy rating to the company’s stock. Based on data from MarketBeat, the company currently has a consensus rating of “Buy” and an average target price of $107.67.

Insider Transactions at Encompass Health

In other Encompass Health news, CAO Andrew L. Price sold 5,042 shares of Encompass Health stock in a transaction on Thursday, February 13th. The shares were sold at an average price of $98.29, for a total transaction of $495,578.18. Following the completion of the sale, the chief accounting officer now owns 69,164 shares of the company’s stock, valued at $6,798,129.56. This trade represents a 6.79 % decrease in their position. The sale was disclosed in a filing with the SEC, which is available at this hyperlink. 2.10% of the stock is owned by insiders.

Encompass Health Stock Up 3.0 %

Shares of Encompass Health stock opened at $99.99 on Tuesday. The company has a quick ratio of 1.04, a current ratio of 1.05 and a debt-to-equity ratio of 0.84. Encompass Health Co. has a 12-month low of $76.11 and a 12-month high of $104.55. The firm has a market capitalization of $10.07 billion, a PE ratio of 22.42, a price-to-earnings-growth ratio of 2.31 and a beta of 0.92. The stock’s fifty day moving average is $98.13 and its 200-day moving average is $97.20.

Encompass Health (NYSE:EHC) last released its earnings results on Thursday, February 6th. The company reported $1.17 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.05 by $0.12. Encompass Health had a return on equity of 17.56% and a net margin of 8.48%. Equities analysts anticipate that Encompass Health Co. will post 4.8 earnings per share for the current year.

Encompass Health Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Tuesday, April 15th. Stockholders of record on Tuesday, April 1st will be issued a $0.17 dividend. The ex-dividend date is Tuesday, April 1st. This represents a $0.68 dividend on an annualized basis and a dividend yield of 0.68%. Encompass Health’s dividend payout ratio is 15.25%.

Encompass Health Profile

Encompass Health Corporation provides post-acute healthcare services in the United States and Puerto Rico. It owns and operates inpatient rehabilitation hospitals that provide medical, nursing, therapy, and ancillary services. The company provides specialized rehabilitative treatment on an inpatient basis to patients who have experienced physical or cognitive disabilities or injuries due to medical conditions, such as strokes, hip fractures, and various debilitating neurological conditions.